EP0491844A4 - Peptides including ctl epitopes of hiv proteins and use thereof - Google Patents

Peptides including ctl epitopes of hiv proteins and use thereof

Info

Publication number
EP0491844A4
EP0491844A4 EP19900914632 EP90914632A EP0491844A4 EP 0491844 A4 EP0491844 A4 EP 0491844A4 EP 19900914632 EP19900914632 EP 19900914632 EP 90914632 A EP90914632 A EP 90914632A EP 0491844 A4 EP0491844 A4 EP 0491844A4
Authority
EP
European Patent Office
Prior art keywords
ctl epitopes
peptides including
hiv proteins
including ctl
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900914632
Other versions
EP0491844A1 (en
Inventor
Thomas Fuerst
Scott Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
MedImmune LLC
Original Assignee
US Department of Health and Human Services
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, MedImmune LLC filed Critical US Department of Health and Human Services
Publication of EP0491844A1 publication Critical patent/EP0491844A1/en
Publication of EP0491844A4 publication Critical patent/EP0491844A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19900914632 1989-09-19 1990-09-19 Peptides including ctl epitopes of hiv proteins and use thereof Withdrawn EP0491844A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40959689A 1989-09-19 1989-09-19
US409596 1989-09-19

Publications (2)

Publication Number Publication Date
EP0491844A1 EP0491844A1 (en) 1992-07-01
EP0491844A4 true EP0491844A4 (en) 1993-02-17

Family

ID=23621182

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900914632 Withdrawn EP0491844A4 (en) 1989-09-19 1990-09-19 Peptides including ctl epitopes of hiv proteins and use thereof

Country Status (4)

Country Link
EP (1) EP0491844A4 (en)
JP (1) JPH05502442A (en)
CA (1) CA2025634A1 (en)
WO (1) WO1991004051A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205102B1 (en) 1983-09-15 2007-04-17 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA
GB8423659D0 (en) 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
GB8429099D0 (en) 1984-11-16 1984-12-27 Pasteur Institut Closed dna sequences
US7232654B1 (en) 1983-09-15 2007-06-19 Institut Pasteur DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)
US7045130B1 (en) 1984-10-18 2006-05-16 Institut Pasteur Antibodies against antigens of human immunodeficiency virus (HIV-1)
US5705612A (en) * 1984-10-18 1998-01-06 Institut Pasteur And Centre National De La Recherche Scientifique NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
US5980900A (en) * 1984-10-18 1999-11-09 Institut Pasteur And Centre National De La Recherche Scientifique Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)
US6894152B1 (en) 1984-11-16 2005-05-17 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5993819A (en) * 1987-09-08 1999-11-30 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
EP0521220A1 (en) 1991-06-14 1993-01-07 Institut Pasteur Recombinant immunogenic actinomycetale
ATE190226T1 (en) * 1991-12-02 2000-03-15 Univ Texas COMPOSITIONS FOR TRIGGERING CYTOTOXIC T-LYMPHOCYTES AGAINST VIRUSES
WO1993019775A1 (en) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
KR100547049B1 (en) * 1996-10-10 2006-02-01 프로브 인터내쇼날 Compositions and Methods for Treating Viral Infections
DE60043856D1 (en) 1999-12-23 2010-04-01 Medical Res Council IMPROVEMENTS IN OR RELATED TO IMMUNE RESOLUTIONS AGAINST HIV
WO2001056355A2 (en) 2000-02-04 2001-08-09 Duke University Human immunodeficiency virus vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273716A2 (en) * 1986-12-30 1988-07-06 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
WO1989002277A2 (en) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273716A2 (en) * 1986-12-30 1988-07-06 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
WO1989002277A2 (en) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOTECHNOLOGY vol. 3, October 1985, NEW YORK US pages 905 - 909 TSE WEN CHANG ET AL. 'Detection of antibodies to human T-cell lymphotropic virus-III (HTLV-III) with an immunoassay employing a recombinant Escherichia coli-derived viral antigenic peptide' *
NATURE vol. 336, no. 6198, 1 December 1988, LONDON GB pages 484 - 487 DOUGLAS F. NIXON ET AL. 'HIV-1 gag-specific cytotoxic T lymphocites defined with recombinant vaccinia virus and synthetic peptides' *
See also references of WO9104051A1 *

Also Published As

Publication number Publication date
WO1991004051A1 (en) 1991-04-04
JPH05502442A (en) 1993-04-28
CA2025634A1 (en) 1991-03-20
EP0491844A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
IL94243A0 (en) Fusion polypeptide and its preparation
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
NZ224046A (en) Hiv antigenic peptide fragments and their use
AU633294B2 (en) Motilin-like polypeptide and use thereof
IL79290A0 (en) Preparation of proteins and polypeptides
GB2203740B (en) Novel peptides, their preparation and use
AP8900114A0 (en) Expression of hiv binding proteins
ZA875633B (en) Recombinant htlv-iii proteins and uses thereof
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
IL87730A0 (en) Peptides and antibodies
NZ227594A (en) Human interleukin-1alpha and preparations thereof
AU2117388A (en) Recombinant htlv-iii proteins and uses thereof
EP0404835A4 (en) Novel recombinant vaccinia virus expression vectors and method of selecting same
YU219289A (en) Recombinant hybride proteins of interleucine-2
GB2193206B (en) Preparation of taurine-containing peptides
ZA877825B (en) "peptide preparations"
ZA907279B (en) Antibodies and proteins
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
IE893135L (en) Hiv proteins and peptides
IE882454L (en) Novel hiv proteins and peptides useful for diagnosis or¹treatment of aids
GB8924883D0 (en) Expression vector and polypeptide synthesis
ZA883261B (en) Recombinant htlv-iii proteins and uses thereof
IE872013L (en) "recombinant htlv-iii proteins and uses thereof"

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19921230

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950403